The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity

Cell

Volumn 167, Issue 6, 2016, Pages 1525-1539.e17

  Moroishi, Toshiro ^a   Hayashi, Tomoko ^b   Pan, Wei Wei ^a,c   Fujita, Yu ^a   Holt, Matthew V ^d   Qin, Jun ^d   Carson, Dennis A ^b   Guan, Kun Liang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c JIAXING UNIVERSITY   (China)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

B16 melanoma; cancer immunity; exosome; Hippo; immunotherapy; interferon; LATS; TAZ; Toll like receptor; YAP

Indexed keywords

CD45 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LARGE TUMOR SUPPRESSOR 1 PROTEIN; LARGE TUMOR SUPPRESSOR 2 PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR SUPPRESSOR PROTEIN; TUMOR VACCINE; UNCLASSIFIED DRUG; CANCER VACCINE; LATS1 PROTEIN, MOUSE; LATS2 PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PRESENTATION; EXOSOME; GENE DELETION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HIPPO PATHWAY; HUMORAL IMMUNITY; IN VITRO STUDY; INTRACELLULAR SIGNALING; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SINGLE DRUG DOSE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR IMMUNOGENICITY; TUMOR REGRESSION; ANIMAL; BAGG ALBINO MOUSE; C3H MOUSE; C57BL MOUSE; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; NEOPLASM; SIGNAL TRANSDUCTION;

ANIMALS; CANCER VACCINES; GENE DELETION; IMMUNE TOLERANCE; IMMUNOTHERAPY; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 85000415174     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.11.005     Document Type: Article

References (41)

1. Barry, E.R., Morikawa, T., Butler, B.L., Shrestha, K., de la Rosa, R., Yan, K.S., Fuchs, C.S., Magness, S.T., Smits, R., Ogino, S., et al. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 493 (2013), 106–110.
2. Camargo, F.D., Gokhale, S., Johnnidis, J.B., Fu, D., Bell, G.W., Jaenisch, R., Brummelkamp, T.R., YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 17 (2007), 2054–2060.
3. Chiappinelli, K.B., Strissel, P.L., Desrichard, A., Li, H., Henke, C., Akman, B., Hein, A., Rote, N.S., Cope, L.M., Snyder, A., et al. Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses. Cell 162 (2015), 974–986.
4. Cottini, F., Hideshima, T., Xu, C., Sattler, M., Dori, M., Agnelli, L., ten Hacken, E., Bertilaccio, M.T., Antonini, E., Neri, A., et al. Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers. Nat. Med. 20 (2014), 599–606.
5. Dewey, E.B., Sanchez, D., Johnston, C.A., Warts phosphorylates mud to promote pins-mediated mitotic spindle orientation in Drosophila, independent of Yorkie. Curr. Biol. 25 (2015), 2751–2762.
6. Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S.A., Gayyed, M.F., Anders, R.A., Maitra, A., Pan, D., Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130 (2007), 1120–1133.
7. Dranoff, G., Experimental mouse tumour models: what can be learnt about human cancer immunology?. Nat. Rev. Immunol. 12 (2011), 61–66.
8. Fuertes, M.B., Woo, S.R., Burnett, B., Fu, Y.X., Gajewski, T.F., Type I interferon response and innate immune sensing of cancer. Trends Immunol. 34 (2013), 67–73.
9. Gajewski, T.F., Schreiber, H., Fu, Y.X., Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol. 14 (2013), 1014–1022.
10. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144 (2011), 646–674.
11. Hansen, C.G., Moroishi, T., Guan, K.L., YAP and TAZ: a nexus for Hippo signaling and beyond. Trends Cell Biol. 25 (2015), 499–513.
12. Harvey, K.F., Zhang, X., Thomas, D.M., The Hippo pathway and human cancer. Nat. Rev. Cancer 13 (2013), 246–257.
13. Johnson, R., Halder, G., The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat. Rev. Drug Discov. 13 (2014), 63–79.
14. Junt, T., Barchet, W., Translating nucleic acid-sensing pathways into therapies. Nat. Rev. Immunol. 15 (2015), 529–544.
15. Keder, A., Rives-Quinto, N., Aerne, B.L., Franco, M., Tapon, N., Carmena, A., The hippo pathway core cassette regulates asymmetric cell division. Curr. Biol. 25 (2015), 2739–2750.
16. Komurov, K., Dursun, S., Erdin, S., Ram, P.T., NetWalker: a contextual network analysis tool for functional genomics. BMC Genomics, 13, 2012, 282.
17. Lei, Z.G., Ren, X.H., Wang, S.S., Liang, X.H., Tang, Y.L., Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma. Onco Targets Ther. 9 (2016), 545–555.
18. Liu, B., Zheng, Y., Yin, F., Yu, J., Silverman, N., Pan, D., Toll receptor-mediated Hippo signaling controls innate immunity in Drosophila. Cell 164 (2016), 406–419.
19. Meng, Z., Moroishi, T., Mottier-Pavie, V., Plouffe, S.W., Hansen, C.G., Hong, A.W., Park, H.W., Mo, J.S., Lu, W., Lu, S., et al. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway. Nat. Commun., 6, 2015, 8357.
20. Meng, Z., Moroishi, T., Guan, K.L., Mechanisms of Hippo pathway regulation. Genes Dev. 30 (2016), 1–17.
21. Mi, H., Muruganujan, A., Casagrande, J.T., Thomas, P.D., Large-scale gene function analysis with the PANTHER classification system. Nat. Protoc. 8 (2013), 1551–1566.
22. Mizuno, H., Kitada, K., Nakai, K., Sarai, A., PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med. Genomics, 2, 2009, 18.
23. Mori, M., Triboulet, R., Mohseni, M., Schlegelmilch, K., Shrestha, K., Camargo, F.D., Gregory, R.I., Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell 156 (2014), 893–906.
24. Moroishi, T., Hansen, C.G., Guan, K.L., The emerging roles of YAP and TAZ in cancer. Nat. Rev. Cancer 15 (2015), 73–79.
25. Moroishi, T., Park, H.W., Qin, B., Chen, Q., Meng, Z., Plouffe, S.W., Taniguchi, K., Yu, F.X., Karin, M., Pan, D., Guan, K.L., A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev. 29 (2015), 1271–1284.
26. Moya, I.M., Halder, G., Discovering the Hippo pathway protein-protein interactome. Cell Res. 24 (2014), 137–138.
27. Nowell, C.S., Odermatt, P.D., Azzolin, L., Hohnel, S., Wagner, E.F., Fantner, G.E., Lutolf, M.P., Barrandon, Y., Piccolo, S., Radtke, F., Chronic inflammation imposes aberrant cell fate in regenerating epithelia through mechanotransduction. Nat. Cell Biol. 18 (2016), 168–180.
28. Pico de Coaña, Y., Choudhury, A., Kiessling, R., Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system. Trends Mol. Med. 21 (2015), 482–491.
29. Ran, F.A., Hsu, P.D., Wright, J., Agarwala, V., Scott, D.A., Zhang, F., Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8 (2013), 2281–2308.
30. Robbins, P.D., Morelli, A.E., Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol. 14 (2014), 195–208.
31. Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., Selbach, M., Global quantification of mammalian gene expression control. Nature 473 (2011), 337–342.
32. Senovilla, L., Vitale, I., Martins, I., Tailler, M., Pailleret, C., Michaud, M., Galluzzi, L., Adjemian, S., Kepp, O., Niso-Santano, M., et al. An immunosurveillance mechanism controls cancer cell ploidy. Science 337 (2012), 1678–1684.
33. Sharma, P., Allison, J.P., Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 161 (2015), 205–214.
34. Sistigu, A., Yamazaki, T., Vacchelli, E., Chaba, K., Enot, D.P., Adam, J., Vitale, I., Goubar, A., Baracco, E.E., Remédios, C., et al. Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat. Med. 20 (2014), 1301–1309.
35. Taniguchi, K., Wu, L.W., Grivennikov, S.I., de Jong, P.R., Lian, I., Yu, F.X., Wang, K., Ho, S.B., Boland, B.S., Chang, J.T., et al. A gp130-Src-YAP module links inflammation to epithelial regeneration. Nature 519 (2015), 57–62.
36. Wang, H., Du, Y.C., Zhou, X.J., Liu, H., Tang, S.C., The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy. Cancer Metastasis Rev. 33 (2014), 173–181.
37. Yáñez-Mó, M., Siljander, P.R., Andreu, Z., Zavec, A.B., Borràs, F.E., Buzas, E.I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles, 4, 2015, 27066.
38. Yu, F.X., Zhao, B., Guan, K.L., Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 163 (2015), 811–828.
39. Zhao, B., Wei, X., Li, W., Udan, R.S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21 (2007), 2747–2761.
40. Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J.D., Wang, C.Y., Chinnaiyan, A.M., et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22 (2008), 1962–1971.
41. Zhou, D., Conrad, C., Xia, F., Park, J.S., Payer, B., Yin, Y., Lauwers, G.Y., Thasler, W., Lee, J.T., Avruch, J., Bardeesy, N., Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16 (2009), 425–438.